Metraipolis › archive › dc_800adc3265dd

A pathology-based surrogate model for chemotherapy decision-making in intermediate-risk luminal breast cancer: validation of histologic grade and Ki67 in a… — Europe PMC PMID:41728598

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41728598
DOI
10.3389/fmed.2026.1727768
License (as archived)
solo-consultazione
Archived
2026-11-06T02:50:40.455Z
SHA-256 of the archived text
eb679652173323050e7d941fadf8d2a61e68c1a821bca11aa83c8c543ef75855
Stable URL of this page
https://metraipolis.com/documento/dc_800adc3265dd

How to cite

A pathology-based surrogate model for chemotherapy decision-making in intermediate-risk luminal breast cancer: validation of histologic grade and Ki67 in a… — Europe PMC PMID:41728598 — Europe PMC (en), https://europepmc.org/article/MED/41728598 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_800adc3265dd (Metraipolis archive dc_800adc3265dd, sha256 eb679652173323050e7d941fadf8d2a61e68c1a821bca11aa83c8c543ef75855)
BibTeX
@misc{dc800adc3265dd,
  title = {A pathology-based surrogate model for chemotherapy decision-making in intermediate-risk luminal breast cancer: validation of histologic grade and Ki67 in a… — Europe PMC PMID:41728598},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41728598},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_800adc3265dd; sha256 eb679652173323050e7d941fadf8d2a61e68c1a821bca11aa83c8c543ef75855},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41728598. Agents can read the archived copy with the MCP tool read_document.